PRELUDE-BTK Study Results Presented at LINC Confirms Serranator Device Novel Mechanism of Action

Fe bruary 1, 2021 PRELUDE-BTK Study was presented at this year’s LINC Symposium on January 29th. PRELUDE-BTK Study, was a prospective, single-arm, multi-center feasibility study to show the safety and efficacy of Serration Angioplasty. The study was led by co-Principal Investigators, Drs. Andrew Holden (Auckland, New Zealand), who presented the data, and Michael Lichtenberg (Arnsberg, […]